Drug Shortage Report for CLINDAMYCIN INJECTION USP

Last updated on 2024-01-24 History
Report ID 205789
Drug Identification Number 02230535
Brand name CLINDAMYCIN INJECTION USP
Common or Proper name Clindamycin
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 60ml
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2023-10-02
Estimated end date 2024-02-02
Actual end date 2024-01-23
Shortage status Resolved
Updated date 2024-01-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-01-24 English Compare
v9 2024-01-23 French Compare
v8 2024-01-23 English Compare
v7 2023-12-11 French Compare
v6 2023-12-11 English Compare
v5 2023-11-27 French Compare
v4 2023-11-27 English Compare
v3 2023-10-03 English Compare
v2 2023-10-02 French Compare
v1 2023-10-02 English Compare

Showing 1 to 10 of 10